ArticleCureus2026
Epidemiology and Performance After Achilles Tendon Rupture in National Basketball Association (NBA) Players: A Retrospective Case Series Rationale.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Achilles tendon (AT) ruptures are among the most severe injuries sustained by National Basketball Association (NBA) players, with prolonged recovery times and documented long-term impact on performance. The 2024-2025 season witnessed a record-high number of these injuries, including multiple high-profile cases, prompting renewed interest in understanding the burden and epidemiological trends of AT ruptures in professional basketball. Purpose The purpose of this study is to characterize the epidemiology of complete AT ruptures in NBA players over the past 15 seasons and explore trends in player demographics and performance after return to play. Methods A retrospective review was conducted using publicly available data on NBA players who experienced complete AT ruptures between 2010 and 2025. Inclusion was limited to players who returned to NBA competition within two seasons and had no prior same-side lower-extremity (LE) surgeries. Pre- and post-injury minutes per game (MPG) and player efficiency rating (PER) were compared using paired t-tests. Subgroup analyses were performed based on age, height, and weight. Results Among the 12 included players, the average age at the time of injury was 27.9 years, with an average of 9.25 months missed. There was a significant decline in MPG post-injury (p = 0.0009, d = 1.31), while the decline in PER trended toward significance (p = 0.0072, d = 0.95). On average, MPG and PER decreased by 20.2% and 21.9%, respectively. Younger players (≤28 years) represented a growing share of recent injuries. Conclusion AT ruptures result in substantial decreases in performance and prolonged absences, with possible trends toward earlier injury onset. Further research is needed to elucidate the causes of this recent increase in such a profound injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.